13G

Company

Atara Biotherapeutics, Inc.

Filed

April 21, 2017

Accession Number

0001172661-17-000938

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →